← Banking With Billy News
Rigel Pharmaceuticals said VEPPANU is now commercially available in the U.S., launching the first approved therapy in a new treatment class. The rollout follows
BWB News TV • 2026-08-14 17:06 UTC • By Billy Odell Tucker-Robinson
Rigel Pharmaceuticals said VEPPANU is now commercially available in the U.S., launching the first approved therapy in a new treatment class. The rollout follows the FDA’s May approval of vepdegestrant and marks a key commercial milestone.
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly